{"id":15568,"date":"2020-01-16T17:09:04","date_gmt":"2020-01-16T17:09:04","guid":{"rendered":"https:\/\/tuavaluo.com\/avaluo\/2020\/01\/16\/credit-suisse-eleva-el-precio-de-grifols-a-la-espera-de-que-confirme-los-datos-de-ambar\/"},"modified":"2020-01-16T17:09:04","modified_gmt":"2020-01-16T17:09:04","slug":"credit-suisse-eleva-el-precio-de-grifols-a-la-espera-de-que-confirme-los-datos-de-ambar","status":"publish","type":"post","link":"https:\/\/tuavaluo.com\/avaluo\/2020\/01\/16\/credit-suisse-eleva-el-precio-de-grifols-a-la-espera-de-que-confirme-los-datos-de-ambar\/","title":{"rendered":"Credit Suisse eleva el precio de Grifols a la espera de que confirme los datos de AMBAR"},"content":{"rendered":"<div class=\"read-more-links\">\n<h5>Noticia relacionada<\/h5>\n<p><a class=\"readMore\" href=\"https:\/\/www.bolsamania.com\/noticias\/empresas\/grifols-dos-dias-hora-de-la-verdad-con-su-estudio-ambar-alzheimer--7145950.html\" rel=\"noopener noreferrer\" target=\"_blank\" data-id=\"7145950\" rel=\"nofollow\" ><\/p>\n<figure><img class=\"lazy\" title=\"Leer m&#xE1;s\" data-original=\"https:\/\/img4.s3wfg.com\/web\/img\/images_uploaded\/8\/9\/ep_grifols_y_mondragon_se_alian_para_desarrollar_tecnologia_aplicada_al_sector_salud_285x185.jpg\" data-src=\"https:\/\/img4.s3wfg.com\/web\/img\/images_uploaded\/8\/9\/ep_grifols_y_mondragon_se_alian_para_desarrollar_tecnologia_aplicada_al_sector_salud_285x185.jpg\" \/><\/figure>\n<p>Grifols, a dos d\u00edas de afrontar \u00abla hora de la verdad\u00bb con su estudio AMBAR de Alzheimer <\/a><\/div>\n<p>\u00abSeguimos esperando otro informe que confirme sus cifras publicadas en marzo de 2018\u00bb, apuntan los expertos de Credit Suisse.<\/p>\n<p>Los suizos recapitulan y aseveran que \u00aben 2019, Grifols ha logrado mejorar su posicionamiento en cinco de los seis par\u00e1metros que medimos\u00bb. A su vez, recuerdan que<strong> \u00abCLS es su rival m\u00e1s cercano y, a\u00fan as\u00ed, sigue estando lejos de su valoraci\u00f3n\u00bb.<\/strong><\/p>\n<p>De cara a 2020, Credit Suisse se\u00f1ala dos catalizadores en el primer trimestre de la biofarmac\u00e9utica: la citada confirmaci\u00f3n de las cifras de AMBAR y el cierre de la operaci\u00f3n de comrpa de Shanghai RAAS. Ambas, son de \u00abalta sensibilidad\u00bb para la cotizaci\u00f3n de Grifols.<\/p>\n<p>&#013;<br \/>\nSource: Bolsamania.com<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Noticia relacionada Grifols, a dos d\u00edas de afrontar \u00abla hora de la verdad\u00bb con su estudio AMBAR de Alzheimer \u00abSeguimos&#8230;<\/p>\n","protected":false},"author":3,"featured_media":15569,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[104],"tags":[99],"_links":{"self":[{"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/posts\/15568"}],"collection":[{"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/comments?post=15568"}],"version-history":[{"count":0,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/posts\/15568\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/media\/15569"}],"wp:attachment":[{"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/media?parent=15568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/categories?post=15568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tuavaluo.com\/avaluo\/wp-json\/wp\/v2\/tags?post=15568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}